Pharmaceuticals
-
Risks for elderly of stopping statins
Coming off statins at the age of 75 can significantly raise the risk of cardiovascular events, researchers warn today. Read more
-
Drug-resistance study highlights infection control role
Infection control in hospitals may be the key to stopping the spread of antibiotic resistant strains of Klebsiella pneumonia, researchers said last night. Read more
-
Plea to tackle hepatitis
Just six billion dollars a year would prevent millions of premature deaths from hepatitis over the next decade, the World Health Organisation says today. Read more
-
Drug resistant malaria spreads in Asia
Drug-resistant malaria is spreading rapidly across south-east Asia, researchers warn today. Read more
-
Health a global problem – CMO
Diseases increasingly fail to respect international borders – making global cooperation in health vital, the Chief Medical Officer of England says today. Read more
-
DRC Ebola – still no closer to elimination
The Democratic Republic of Congo has reported a new outbreak of Ebola in the city of Goma – while two Ebola responders have been murdered in their home, the director-general of the World Health Organisation (WHO) reported yesterday. Read more
-
Treatment hope for combined breast and lung cancer drugs
Combining targeted drugs for breast and lung cancer could be used in patients with other tumour types to help them overcome treatment resistance, British researchers report today. Read more
-
Most new drugs have no proven benefit – claim
More than 50% of new drugs are approved with little evidence that they offer added benefits, researchers claim today. Read more
-
Immunotherapy hope for bowel cancer patients
Immunotherapy could benefit people who have stopped responding to a bowel cancer drug, according to a major new study. Read more
-
Combination therapy improves advanced bowel cancer survival rates
A combination of targeted therapies can improve survival in patients with advanced bowel cancer and should replace chemotherapy, new data has revealed. Read more
